Skip to main content

Colchicine Price Increase Tied to Poorer Gout Control Over a Decade

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, May 17, 2023 -- A sharp increase in colchicine prices in 2010 was associated with a sustained decrease in colchicine use and poorer disease control over a decade, according to a study published online May 8 in JAMA Internal Medicine.

Dan P. Ly, M.D., Ph.D., from University of California, Los Angeles, and colleagues examined the association between the large 2010 price increase in colchicine and long-term changes in colchicine use, substitution with other drugs, and health care use. The analysis included patients with gout with employer-sponsored insurance from 2007 through 2019.

The researchers found a 15.9-fold price increase, with the mean out-of-pocket price increasing from $7.37 to $39.49. Concurrently, colchicine use declined from 35.0 to 27.3 pills per patient in year 1 and to 22.6 pills per patient in 2019. Adjusted allopurinol use rose by 7.8 pills per patient in year 1, a 7.6 percent increase from baseline, and by 33.1 pills per patient through 2019, a 32.0 percent increase from baseline over the decade. In year 1, there was no significant change in adjusted oral corticosteroid use, but there was an increase by 1.5 pills per patient through 2019, an 8.3 percent increase from baseline over the decade. Adjusted emergency department visits for gout rose by 0.02 per patient in year 1, a 21.5 percent increase, and by 0.05 per patient through 2019, a 39.8 percent increase over the decade. Over the decade, there was a 10.5 percent increase in adjusted rheumatology visits for gout.

"Increased emergency department and rheumatology visits for gout over the same period suggest poorer disease control," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2023

Read this next

Risk for Benign Prostatic Hyperplasia Increased for Patients With Gout

WEDNESDAY, Jan. 31, 2024 -- Patients with gout, especially those younger than 60 years, have an increased risk for benign prostatic hyperplasia (BPH), according to a study...

Inflammatory Bowel Disease Tied to Higher Risk for Gout

TUESDAY, Oct. 3, 2023 -- Inflammatory bowel disease (IBD) is strongly associated with gout, according to a study published online Sept. 1 in JGH Open. Osama Hamid, M.B.B.S., from...

Body Mass Index Affects Risk for Rheumatic Disease

FRIDAY, Aug. 4, 2023 -- Higher body mass index (BMI) increases the risk for rheumatic disease and is a stronger risk factor for psoriatic arthropathy and gout in women, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.